Rapid-infusion Isatuximab in Relapsed/Refractory Multiple Myeloma
NCT04802031
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Low accrual
Conditions
Relapsed Multiple Myeloma
Refractory Multiple Myeloma
Interventions
BIOLOGICAL:
Rapid Infusion Isatuximab
Sponsor
Thomas Martin, MD